TherapeuticsMD(TXMD)
$1.82-0.03 (-1.62%)
TXMD
TherapeuticsMD earnings date
$1.82
At close:-0.03 (-1.62%)
Want to see TXMD full AI Analyst Report?
TherapeuticsMD (TXMD) Q2 2021 Earnings Report
2,250 Followers
TXMD Q2 2021 EPS Results
- Actual EPS
- -$5.50
- Consensus EPS
- -$5.50
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$9.50
TXMD Q2 2021 Revenue Results
- Actual Revenue
- $23.00M
- Expected Revenue
- $22.11M
- Beat/Miss
- Beat by +$887.00K
- YoY Revenue Growth
- +114.94%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/04/2021
- Time
- Before Open
- Conference Call
- Wednesday, August 4, 2021
TXMD Upcoming Earnings
TherapeuticsMD's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
TXMD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―- | 0.01 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | ―0.01 | 0.05 | -72.92% (-0.04) | |
| May 12, 2026 | 2026 (Q1) | ―0.01 | -0.06 | 114.29% (+0.06) | |
| Mar 30, 2026 | 2025 (Q4) | ―-0.05 | 0.02 | -345.45% (-0.08) | |
| Nov 12, 2025 | 2025 (Q3) | ―0.01 | -0.05 | 126.00% (+0.06) | |
| Aug 12, 2025 | 2025 (Q2) | ―0.05 | -0.09 | 153.33% (+0.14) | |
| May 13, 2025 | 2025 (Q1) | ―-0.06 | -0.07 | 20.00% (+0.01) | |
| Mar 27, 2025 | 2024 (Q4) | ―0.02 | -0.13 | 116.92% (+0.15) | |
| Nov 12, 2024 | 2024 (Q3) | ―-0.05 | -0.13 | 61.54% (+0.08) | |
| Aug 12, 2024 | 2024 (Q2) | ―-0.09 | -0.24 | 62.50% (+0.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
